JP2003521509A5 - - Google Patents

Download PDF

Info

Publication number
JP2003521509A5
JP2003521509A5 JP2001556244A JP2001556244A JP2003521509A5 JP 2003521509 A5 JP2003521509 A5 JP 2003521509A5 JP 2001556244 A JP2001556244 A JP 2001556244A JP 2001556244 A JP2001556244 A JP 2001556244A JP 2003521509 A5 JP2003521509 A5 JP 2003521509A5
Authority
JP
Japan
Prior art keywords
alkyl
alkyloxy
hydrogen
amino
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001556244A
Other languages
English (en)
Japanese (ja)
Other versions
JP5491681B2 (ja
JP2003521509A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/001032 external-priority patent/WO2001056552A2/en
Publication of JP2003521509A publication Critical patent/JP2003521509A/ja
Publication of JP2003521509A5 publication Critical patent/JP2003521509A5/ja
Application granted granted Critical
Publication of JP5491681B2 publication Critical patent/JP5491681B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001556244A 2000-02-04 2001-02-01 乳ガンの治療のためのファルネシルタンパク質トランスフェラーゼ阻害剤 Expired - Lifetime JP5491681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200373 2000-02-04
EP00200373.9 2000-02-04
PCT/EP2001/001032 WO2001056552A2 (en) 2000-02-04 2001-02-01 Farnesyl protein transferase inhibitors for treating breast cancer

Publications (3)

Publication Number Publication Date
JP2003521509A JP2003521509A (ja) 2003-07-15
JP2003521509A5 true JP2003521509A5 (cg-RX-API-DMAC10.html) 2009-06-18
JP5491681B2 JP5491681B2 (ja) 2014-05-14

Family

ID=8170976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001556244A Expired - Lifetime JP5491681B2 (ja) 2000-02-04 2001-02-01 乳ガンの治療のためのファルネシルタンパク質トランスフェラーゼ阻害剤

Country Status (13)

Country Link
US (4) US20030027839A1 (cg-RX-API-DMAC10.html)
EP (1) EP1255537B1 (cg-RX-API-DMAC10.html)
JP (1) JP5491681B2 (cg-RX-API-DMAC10.html)
AT (1) ATE323474T1 (cg-RX-API-DMAC10.html)
AU (1) AU2001233726A1 (cg-RX-API-DMAC10.html)
CA (1) CA2396865C (cg-RX-API-DMAC10.html)
CY (1) CY1105477T1 (cg-RX-API-DMAC10.html)
DE (1) DE60118889T2 (cg-RX-API-DMAC10.html)
DK (1) DK1255537T3 (cg-RX-API-DMAC10.html)
ES (1) ES2262626T3 (cg-RX-API-DMAC10.html)
PT (1) PT1255537E (cg-RX-API-DMAC10.html)
SI (1) SI1255537T1 (cg-RX-API-DMAC10.html)
WO (1) WO2001056552A2 (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7342016B2 (en) * 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
WO2002064142A1 (en) * 2001-02-15 2002-08-22 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with antiestrogen agents
WO2003047697A2 (en) * 2001-11-30 2003-06-12 Schering Corporation Use of an farsenyl protein tranferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
US7102251B2 (en) * 2003-08-22 2006-09-05 Distributed Power, Inc. Bi-directional multi-port inverter with high frequency link transformer
BRPI0416316A (pt) * 2003-11-06 2007-01-09 Schering Corp combinação de um inibidor da farnesil transferase com um agente anti-hormonal para o tratamento de cáncer de mama
JP2007516258A (ja) 2003-12-12 2007-06-21 ワイス 心臓血管の疾患治療に有用なキノリン誘導体
CA2559221A1 (en) * 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20050272068A1 (en) * 2004-03-18 2005-12-08 The Brigham And Women's Hospital, Inc. UCH-L1 expression and cancer therapy
WO2005089515A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20070293539A1 (en) * 2004-03-18 2007-12-20 Lansbury Peter T Methods for the treatment of synucleinopathies
US20050288298A1 (en) * 2004-03-18 2005-12-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
CA2559285A1 (en) * 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20060194821A1 (en) * 2005-02-18 2006-08-31 The Brigham And Women's Hospital, Inc. Compounds inhibiting the aggregation of superoxide dismutase-1
AU2006331542A1 (en) 2005-12-23 2007-07-05 Link Medicine Corporation Treatment of synucleinopathies
WO2009151683A2 (en) * 2008-03-12 2009-12-17 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
AU2009313927A1 (en) * 2008-11-13 2010-05-20 Astrazeneca Ab Azaquinolinone derivatives and uses thereof
US20110060005A1 (en) * 2008-11-13 2011-03-10 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20100331363A1 (en) * 2008-11-13 2010-12-30 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
EP2288195B1 (en) * 2009-08-20 2019-10-23 Samsung Electronics Co., Ltd. Method and apparatus for operating a base station in a wireless communication system
WO2014062655A1 (en) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
MY189505A (en) 2012-10-16 2022-02-16 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of roryt
HK1213887A1 (zh) 2012-10-16 2016-07-15 Janssen Pharmaceutica N.V. RORγt的苯基连接的喹啉基调节剂
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
CA2927182A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Quinolinyl modulators of ror.gamma.t
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
CA2926339A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of roryt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US10471055B2 (en) 2015-08-17 2019-11-12 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
HRP20210544T1 (hr) 2016-11-03 2021-08-20 Kura Oncology, Inc. Inhibitori farneziltransferaze za uporabu u liječenju raka

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69635966T2 (de) * 1995-12-08 2006-11-30 Janssen Pharmaceutica N.V. (Imidazol-5-yl)Methyl-2-Chinolinonderivate als Farnesyl Protein transferase Inhibitoren
US5874442A (en) * 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
US5994364A (en) * 1996-09-13 1999-11-30 Schering Corporation Tricyclic antitumor farnesyl protein transferase inhibitors
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
SK146199A3 (en) * 1997-04-25 2000-06-12 Janssen Pharmaceutica Nv Farnesyltransferase inhibiting quinazolinones
US5925639A (en) * 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
US5852034A (en) * 1997-06-17 1998-12-22 Schering Corporation Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
US6096757A (en) * 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
US6410534B1 (en) * 1998-07-02 2002-06-25 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ID26987A (id) * 1998-07-06 2001-02-22 Janssen Pharmaceutica Nv Inhibitor-inhibitor transferase protein farnesil dengan sifat-sifat peka terhadap sinar radiasi in vivo
CA2341739C (en) * 1998-08-27 2005-07-12 Pfizer Products Inc. Quinolin-2-one derivatives useful as anticancer agents
PT1140935E (pt) * 1998-12-23 2003-10-31 Janssen Pharmaceutica Nv Derivados da quinolina 1,2-ciclizada
AU2292801A (en) * 1999-12-22 2001-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and methods for treatment of breast cancer
JP2003523381A (ja) * 2000-02-24 2003-08-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 投与レジメン
AU2001244166A1 (en) * 2000-02-29 2001-09-12 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
US20020022633A1 (en) * 2000-06-30 2002-02-21 Williams Theresa M. Inhibitors of prenyl-protein transferase

Similar Documents

Publication Publication Date Title
EP1267929A2 (en) Farnesyl protein transferase inhibitor combinations with an her2 antibody
US6838467B2 (en) Dosing regimen
JP5491681B2 (ja) 乳ガンの治療のためのファルネシルタンパク質トランスフェラーゼ阻害剤
JP2003525246A (ja) 白金化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
RU2000100032A (ru) Производные (имидазол-5-ил)метил-2-хинолинона в качестве ингибиторов пролиферации клеток гладкой мышцы
US20040157773A1 (en) Farnesyl protein transferase inhibitors for treating cachexia
JP2013532727A5 (cg-RX-API-DMAC10.html)
AU4780599A (en) Farnesyl protein transferase inhibitors with In Vivo radiosensitizing properties
JP2003525244A (ja) 抗腫瘍性アルキル化剤とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
JP2018505880A5 (cg-RX-API-DMAC10.html)
US20030125326A1 (en) Farnesyl protein transferase inhibitor combinations
EP1261343A2 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
JP2012526766A5 (cg-RX-API-DMAC10.html)
JP7528090B2 (ja) 抗腫瘍組成物
JP2023550902A5 (cg-RX-API-DMAC10.html)
JP2003525236A (ja) ビンカアルカロイドとのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
CA2596084A1 (en) Treatment of metastasized tumors with quinolinone benzimidazole compounds
US20110281813A1 (en) Method of treating c-kit positive relapsed acute myeloid leukemia
JPWO2013137433A1 (ja) 3剤を組み合わせた新規な抗腫瘍剤
JP2013142059A (ja) 腎細胞がん治療剤
CA2761243A1 (en) Anti-tumor agent containing tegafur-gimeracil-oteracil potassium combination drug and oxaliplatin
JP2015199676A (ja) レゴラフェニブを含有する抗腫瘍剤及び抗腫瘍効果増強剤
WO2011152515A1 (ja) インドール化合物を含有する抗腫瘍剤